Shankh Mitra
Analyst · Stifel
Thank you, Mercedes, and good morning, everyone. I will now review our quarterly operating results for different segments of the business, and provide you with an update on our continuing portfolio repositioning efforts. We’re very pleased with our results and are increasing our same-store NOI guidance for the overall portfolio to 2.5% to 3% on the back of significant outperformance on our SHO portfolio, which grew 4.1% year-over-year. I will remind you that we do not update our outlook for the segment level NOI growth throughout the year, but we are tracking towards the top end of our original 1.5% to 3% guidance for the SHO portfolio. Same-store NOI increased 3.4% year-over-year for the entire portfolio. The triple net portfolio continued its reliable performance as our senior housing triple net segment grew 3%. The payments stream remained secure despite a 2 basis points of optical decline in coverage. This decline was primarily driven by the removal of Sagora portfolio, part of which was converted to a RIDEA joint venture as Sagora had higher coverage than the overall triple net portfolio. While industry debate is often focused on RIDEA versus triple net, we have combined the best of both worlds in structuring this relationship. Newer assets in the best of markets are now structured as RIDEA joint venture, while more middle-market assets where we can earn reliable and consistent returns are part of a triple net portfolio. Alignment of interests and downside protections were two of the most important pillars of restructuring. We’re extremely confident in Donny and Bryan’s ability to drive significant value here. The outpatient medical portfolio reported 2.4% NOI growth in Q3. Growth rebounded from Q2, as we expected, due to strong leasing and high tenant retention. Our steady performance and continued growth demonstrates why institutional investors are flowing into this asset class. Our post-acute portfolio, which constitutes 13% of our NOI and approximately 7% of our value, grew same-store NOI at 3.1% for the quarter. Our payments stream remained secure at 1.55 times on EBITDARM and 1.24 times on EBITDAR basis. I would like to remind everyone that management fees are subordinate to rent as defined in our master leases. This decline in coverage was driven by our skilled nursing portfolio as well as our small LTAC portfolio. Specifically focusing on Genesis, it is no secret that skill mix and occupancy have been materially impacted by the evolution of reimbursement model over last few years. However, we are really encouraged by the sequential stabilization of EBITDAR in a majority of our Genesis portfolio. We are confident that Genesis will be a winner in the new value-driven landscape because of its superior clinical abilities. We and other Genesis-graded parties understand the current capital structure is suboptimal. As you know, we’re going through a disposition program that will provide a substantial deleveraging event for Genesis. We have select the counter party -- we have selected the counter parties, and largely negotiated the economics and structure and are currently working towards documentation. Given the current status of this transaction, we cannot further comment on this topic other than to say that upon successful completion of these deals, Genesis will receive approximately $25 million of rent credit and reduced escalators, as you have seen from our last two Genesis transactions. This meaningful deleveraging of Genesis will put the company in a sustainable capital structure and accelerate market share gain, which will help our joint venture partners and our retained interest, while crystallizing value for our shareholders today. As a reminder, we own real estate assets, loans and some equity interest in Genesis. While we cannot guarantee any outcome, we’re confident in our ability to execute and hopeful that you as our shareholders will keep the same faith in us as you did last year to maximize the value of our total capital deployed with Genesis. We are encouraged and grateful for your support in our path of maximizing value for our existing shareholders rather than the short-term temptation of solving fund equation -- exposure equation only to attract the new ones. Our senior housing operating portfolio is the highlight of the quarter, with meaningful outperformance relative to our budget. Occupancy trends were slightly lower than we expected, about 20 basis points, weaker in Canada and U.K., but better in the U.S. This favorable occupancy trends were significantly offset by our pricing power, 30 basis points above budget, which resulted a strong rate growth, up 3.9% year-over-year, and significantly better expense trend, up only 0.8% year-over-year. Both Canada and U.K. outperformed expectations in terms of rate growth. As we mentioned before, our premier operating partners are consistently optimizing the rate and occupancy equation to maximize revenue. We’re very proud that they have achieved this growth while keeping expenses in check. As our operators strike the right balance between excellent care delivery and efficient staffing model, our labor cost continues to moderate from the highs, up 3.6% this quarter versus 4.1% last quarter relative to a peak of 7.4% in Q1 of ‘16. Our group repurchasing and other cost consolidation initiative are been realized through expense savings in food, professional services, insurance, utilities and incentive management fee. We believe our data and analytics-driven asset management approach will continue to help us produce superior results in the long term. Southern California, northern California, Toronto, London, Vancouver and Seattle were significant drivers of growth this quarter. The greater New York MSA has bounced back and produced better-than-portfolio result for the first time in handful of quarters. New England continuous to be challenging, though it is improving sequentially for the second quarter in a row. With respect to different product types, we have observed significant outperformance of both revenue and NOI growth in assisted living versus independent living this quarter. We continue to be encouraged by the greater stickiness of residents in assisted living and memory care assets. So overall, we’re very pleased with the operating performance of our portfolio, innovative structuring with Sagora and progress on our disposition efforts in the post-acute segment of the business. With that, I’ll pass it over to John Goodey, our CFO. John?